Unichem Laboratories is currently trading at Rs. 264.45, up by 8.95 points or 3.50% from its previous closing of Rs. 255.50 on the BSE.
The scrip opened at Rs. 262.00 and has touched a high and low of Rs. 267.65 and Rs. 262.00 respectively.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 304.20 on 04-Aug-2020 and a 52 week low of Rs. 75.10 on 24-Mar-2020.
Last one week high and low of the scrip stood at Rs. 263.50 and Rs. 237.20 respectively. The current market cap of the company is Rs. 1798.87 crore.
The promoters holding in the company stood at 50.93%, while Institutions and Non-Institutions held 10.77% and 38.29% respectively.
Unichem Laboratories has received ANDA approval for its Atenolol and Chlorthalidone Tablets, USP 50 mg/25 mg and 100 mg/25 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENORETIC (atenolol and chlorthalidone) Tablets of Alvogen Malta Operations Atenolol and Chlorthalidone Tablets are indicated for the treatment of hypertension, to lower blood pressure. The product will be commercialized from the company’s Ghaziabad Plant.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company.
